Job Description
IMSciences acquired a promising biotech portfolio and turned it around to incubate APS and develop pre-clinical drugs for oral and GI mucositis, debilitating side effects of chemotherapy and radiation. APS was acquired by IndUS pharma which was subsequently acquired by Pivot Pharmaceuticals.